Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Central Nervous System (CNS) therapeutics Market Research Reports

Titlepublishedprice

Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2016

By Global Markets Direct
"...... on degenerative disease of the motor neuron system. The disorder is named for its underlying pathophysiology, with amyotrophy referring to the atrophy of muscle fibers, which are denervated as their corresponding anterior horn cells degenerate. Later......"
30-Nov-2016$2000

Spinal Cord Injury - Pipeline Review, H2 2016

By Global Markets Direct
"...... al cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually caused by trauma, transverse myelitis, polio, spina bifida or Friedreich's ataxia. Signs and symptoms of spinal cord injury include extreme bac......"
23-Nov-2016$2000

Herpes Simplex Encephalitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... mplex Encephalitis Report is to understand the market and pipeline status of the drugs around the Herpes Simplex Encephalitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Nov-2016$2000

Acute Spinal Cord Injury-Pipeline Insights, 2016

By Delve Insight
"...... y, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA &......"
01-Nov-2016$1250

Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... derstand the market and pipeline status of the drugs around the Meningitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provide......"
01-Nov-2016$2000

Meningitis-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Bacterial (Pyogenic) Meningitis-Pipeline Insights, 2016

By Delve Insight
"...... uding Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, pate......"
01-Nov-2016$1250

Spinal Cord Injury-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... Report is to understand the market and pipeline status of the drugs around the Spinal Cord Injury to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The Delve......"
01-Nov-2016$2000

Global Spinal Cord Partnering 2010 to 2016

By Current Partnering
"...... /> Β• Trends in partnering deals Β• Top deals by value Β• Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreeme......"
01-Nov-2016$1495

Global Neuropathy Partnering 2010 to 2016

By Current Partnering
"...... /> Β• Trends in partnering deals Β• Top deals by value Β• Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreeme......"
01-Nov-2016$1495

Avail upto 50% Discount on below Publisher Reports.